Stock AMWAY AMWAY (MALAYSIA) HOLDINGS
Add to a list
To use this feature you must be a member
Log inSign up

Financials Amway (Malaysia) Holdings

Equities

AMWAY

MYL6351OO000

Pharmaceuticals

End-of-day quote BURSA MALAYSIA
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
7.22 MYR -0.55% Intraday chart for Amway (Malaysia) Holdings -1.23% +22.79%
Apr. 23 Amway Holdings Berhad Announces Retirement of Dato' Abdullah Thalith Bin Md Thani as Independent and Non Executive Member of Audit Committee, Effective 23 May 2024 CI
Apr. 23 Amway Holdings Berhad Announces Retirement of Dato' Abdullah Thalith Bin Md Thani as Independent and Non Executive Director, Effective 23 May 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 938.6 950.1 887.7 821.9 966.6 1,187 - -
Enterprise Value (EV) 1 938.6 950.1 887.7 821.9 966.6 1,187 1,187 1,187
P/E ratio 18.3 x 20.3 x 24.1 x 10.7 x 8.34 x 11.6 x 11.5 x 11.1 x
Yield 3.5% 4.76% 4.44% 7.6% 10.2% 6.65% 6.93% 6.93%
Capitalization / Revenue 0.97 x 0.82 x 0.6 x 0.54 x 0.69 x 0.86 x 0.85 x 0.83 x
EV / Revenue 0.97 x 0.82 x 0.6 x 0.54 x 0.69 x 0.86 x 0.85 x 0.83 x
EV / EBITDA 13.7 x 15.3 x 14 x 7.09 x 6.04 x 8.36 x 8.29 x 8.06 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 4.23 x 4.25 x 4.12 x 3.25 x - - - -
Nbr of stocks (in thousands) 164,386 164,386 164,386 164,386 164,386 164,386 - -
Reference price 2 5.710 5.780 5.400 5.000 5.880 7.220 7.220 7.220
Announcement Date 2/26/20 2/24/21 2/23/22 2/27/23 2/28/24 - - -
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 966.3 1,153 1,486 1,515 1,408 1,375 1,398 1,423
EBITDA 1 68.48 62.19 63.19 115.9 160.1 141.9 143.2 147.2
EBIT 1 59.01 52.43 46.5 98.96 145.2 119.4 126.7 132
Operating Margin 6.11% 4.55% 3.13% 6.53% 10.31% 8.68% 9.06% 9.27%
Earnings before Tax (EBT) 1 64.55 62.33 49.73 103.1 152.6 133.7 134.5 140.6
Net income 1 51.16 46.9 36.78 76.88 115.9 102 102.9 106.8
Net margin 5.29% 4.07% 2.48% 5.08% 8.23% 7.41% 7.36% 7.5%
EPS 2 0.3112 0.2853 0.2237 0.4677 0.7052 0.6205 0.6260 0.6500
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 0.2000 0.2750 0.2400 0.3800 0.6000 0.4800 0.5000 0.5000
Announcement Date 2/26/20 2/24/21 2/23/22 2/27/23 2/28/24 - - -
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 23.3% 21% 16.7% 32.7% 41.3% 30.7% 30.1% 29.2%
ROA (Net income/ Total Assets) 12.1% 10.1% 7.21% 14.1% 19.9% 15.9% 16.2% 16.1%
Assets 1 423.1 463.6 510.3 545.7 583.2 641.2 635.2 663.4
Book Value Per Share 1.350 1.360 1.310 1.540 - - - -
Cash Flow per Share - - - - - - - -
Capex 1 5.38 - - 3.14 - 6 6 6
Capex / Sales 0.56% - - 0.21% - 0.44% 0.43% 0.42%
Announcement Date 2/26/20 2/24/21 2/23/22 2/27/23 2/28/24 - - -
1MYR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Amway (Malaysia) Holdings

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
7.22 MYR
Average target price
7.05 MYR
Spread / Average Target
-2.35%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
AMWAY (MALAYSIA) HOLDINGS Stock Amway (Malaysia) Holdings
+22.79% 249M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.24% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.55% 231B
NOVARTIS AG Stock Novartis AG
+5.27% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.00% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AMWAY Stock
  4. Financials Amway (Malaysia) Holdings